WHO ICTRP trial
The response of vasculitis patients to influenza vaccination compared to healthy…
ACTRN12608000440325 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12608000440325 |
|---|---|
| Public title | The response of vasculitis patients to influenza vaccination compared to healthy individuals |
| Scientific title | The immunological response of patients with anti-neutrophil cytoplasmic antibody (ANCA) vasculitis to the influenza vaccine compared to healthy individuals. |
| Primary sponsor | Royal Adelaide Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Australia |
| Conditions | Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis; Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis;Inflammatory and Immune System - Autoimmune diseases |
| Interventions | Administration of inactivated trivalent influenza vaccine (CSL brand Fluvax). 1.Dosage used 0.5mL 2.Administered as deep subcutaneous injection in deltoid region 3.Single administration of injection only to all participants. 4.Overall… |
| Registration date | Mar 9, 2008 |
| Target size | 100 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: